FindTrial
Sign In

Study to assess the effect of Platelet Rich Plasma in osteoarthritis knee.

Study of efficacy of Platelet Rich Plasma and ultrasonographic changes in cartilage thickness in degenerative osteoarthritis knee

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/023685
Enrollment
30
Registered
2020-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

Intervention1: Platelet rich plasma: Intraarticular injection of 2 ml autologous platelet rich plasma in diagnosed osteoarthritis knee Control Intervention1: Nil: Nil

Sponsors

VMMC and Safdarjung
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of either gender (50-75yrs) of age diagnosed with primary OA knee of tibio-femoral joint as defined by ACR clinical criteria. 2.Radiological grade II, III of knee osteoarthritis according to Kellgren-Lawrence classification.

Exclusion criteria

Exclusion criteria: 1.Patients having secondary OA knee and bleeding disorders. 2. Ipsilateral cruciate or collateral ligament injury within past three months. 3.Intra articular treatment with any product or joint lavage. 4. Any arthroscopic procedure within prior six months. 5. Any knee surgery within prior twelve months.

Design outcomes

Primary

MeasureTime frame
To study the clinical outcome in OA knee following Platelet Rich Plasma injection using Knee injury and Osteoarthritis Outcome Score(KOOS) and Visual Analog Scale(VAS) scoring system.Timepoint: 6 months—

Secondary

MeasureTime frame
To assess the cartilage thickness pre and post PRP injection by ultrasonography.Timepoint: 6 months—

Countries

India

Contacts

Public ContactDeepthi S Johnson

VMMC and Safdarjung Hospital

rkwadhwa79@gmail.com9868182025

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026